Weight-Loss drug wegovy tested as Hair-Pulling treatment
NCT ID NCT07282769
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a weekly injection of semaglutide (Wegovy), a drug used for weight loss and diabetes, can help people with trichotillomania (hair-pulling disorder). Ten adults aged 18-75 with daily hair pulling will receive the drug for several weeks. Researchers will measure changes in hair-pulling severity using a standard rating scale.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- semaglutide (Wegovy)
- What this could lead to
- If it works, this could point toward a new treatment option for trichotillomania, reducing the urge to pull hair.
- What could go wrong
- This is a very small, early-phase trial with only 10 people and no placebo group, so results may not be reliable or generalizable. Semaglutide can cause nausea, vomiting, and other side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAIR PULLING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Everyday therapists? study tests Non-Licensed CBT in hospitals
- Vibrating bracelet may curb Hair-Pulling disorder
- CBD drug shows promise for OCD and tics in tiny study
- Could a Once-Daily pill curb the urge to pull hair?
- Wearable device aims to curb Hair-Pulling disorder
- Behavioral therapy may beat medication for Hair-Pulling and Skin-Picking